Quarterly Result29 Jul 2026, 04:17 pm
Nath Bio-Genes Declares Unaudited Q1 FY27 Results
AI Summary
Nath Bio-Genes (India) Ltd. announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company's Board of Directors approved these results in a meeting held on July 29, 2026. Additionally, the Board approved the date for the 33rd Annual General Meeting to be held on September 24, 2026, via video conference. The financial results include statements for both standalone and consolidated unaudited financial results for the specified quarter, along with the statutory auditors' limited review reports.
Key Highlights
- Unaudited standalone and consolidated financial results for Q1 FY27 declared.
- Board meeting held on July 29, 2026, to approve financial results.
- 33rd Annual General Meeting scheduled for September 24, 2026.
- AGM to be conducted through video conference as per MCA and SEBI circulars.
Price Impact
More from NATHBIOGEN